首页> 外国专利> Targeted delivery of cytotoxic drugs A) to activated lymphocytes in patients iwth transplanted organs, B) as radiosensitizers to cancer cells in paients undergoing radiation therapy, and C) in vitaminpbinding proteins as drug carriers in the diagnosis and treatment of cancer

Targeted delivery of cytotoxic drugs A) to activated lymphocytes in patients iwth transplanted organs, B) as radiosensitizers to cancer cells in paients undergoing radiation therapy, and C) in vitaminpbinding proteins as drug carriers in the diagnosis and treatment of cancer

机译:有针对性地将细胞毒药物A)转移至移植器官患者的活化淋巴细胞中; B)将放射增敏剂作为接受放射治疗的患者的癌细胞; C)将维生素P结合蛋白作为药物载体用于诊断和治疗癌症

摘要

This invention relates to the targeted delivery of cytotoxic drugs A) to lymphocytes responsible for the rejection of transplanted tissues, such as kidneys or hearts or bone marrow cells; B) the use of a non-toxic naturally existing delivery system to transport high concentrations of radiosensitizers to cancer cells; and C) to the targeted delivery of drugs in medical diagnosis and treatment of cancer.
机译:本发明涉及细胞毒性药物A)向负责排斥移植组织(例如肾脏或心脏或骨髓细胞)的淋巴细胞的靶向递送。 B)使用无毒的天然存在的输送系统将高浓度的放射增敏剂转运至癌细胞; C)针对癌症的医学诊断和治疗有针对性地提供药物。

著录项

  • 公开/公告号US2008095802A1

    专利类型

  • 公开/公告日2008-04-24

    原文格式PDF

  • 申请/专利权人 WARD PAGE FAULK;

    申请/专利号US20070952181

  • 发明设计人 WARD PAGE FAULK;

    申请日2007-12-07

  • 分类号A61K35/74;A61K31/337;A61K31/517;A61K38/13;A61P37;A61K38/40;A61K38;A61K31/704;

  • 国家 US

  • 入库时间 2022-08-21 20:14:33

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号